GLAXO

Glaxosmithkline Pharmaceuticals has reported a notable gain of 3.45% on March 7, 2025, outperforming the sector by 3.38%. The stock reached an intraday high of Rs 2780.2, reflecting a rise of 3.77%. Currently, Glaxosmithkline Pharmaceuticals is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong short-term performance. In the broader market, the Sensex opened flat with a slight change of 7.05 points, currently trading at 74,377.42, up by 0.05%. However, the Sensex is below its 50-day moving average, which is also trailing the 200-day moving average. Small-cap stocks are leading the market today, with the BSE Small Cap index gaining 0.9%. Over various time frames, Glaxosmithkline Pharmaceuticals has shown impressive performance. In the past week, the stock has risen by 12.50%, and over the past month, it has increased by 25.70%. Year-to-date, the stock has gained 23.33%, while its performance over the last three years stands at 84.09%.